+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cephalosporin"

From
From
From
From
From
Cephalosporin Markets in China - Product Thumbnail Image

Cephalosporin Markets in China

  • Report
  • October 2024
  • 270 Pages
  • China
From
Cephalosporin Companies in China - Product Thumbnail Image

Cephalosporin Companies in China

  • Report
  • October 2024
  • 59 Pages
  • China
From
Cephalosporin Industry Forecasts - China Focus - Product Thumbnail Image

Cephalosporin Industry Forecasts - China Focus

  • Report
  • October 2024
  • 135 Pages
  • China
From
Loading Indicator

The Cephalosporin market is a segment of the Antibiotics market. Cephalosporins are a class of antibiotics used to treat a wide range of bacterial infections. They are derived from a fungus called Cephalosporium and are divided into four generations based on their antibacterial activity. Cephalosporins are used to treat infections caused by Gram-positive and Gram-negative bacteria, including respiratory, urinary tract, skin, and soft tissue infections. Cephalosporins are widely used in both human and veterinary medicine. They are available in various formulations, including tablets, capsules, suspensions, and injections. The global Cephalosporin market is driven by the increasing prevalence of bacterial infections, the growing demand for generic drugs, and the increasing use of Cephalosporins in veterinary medicine. Some of the major companies in the Cephalosporin market include Pfizer, Merck, Sanofi, Novartis, GlaxoSmithKline, AstraZeneca, and Allergan. Show Less Read more